Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Dr. Desai will be recognized at the American Urological Association's Annual Meeting in Las Vegas, Nevada, in April 2025.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis ...

Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...

The Urology Care Foundation is Encouraging You to Be Proactive for National Kidney Month March is National Kidney Month! BALTIMORE, Feb. 28, 2025 (GLOBE NEWSWIRE) -- March is National Kidney Month, ...

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

Jefferson Regional Hospital’s Urology Associates will be participating in what’s being called a “March Madness Wellness Event ...

Urology of Virginia, a globally recognized leader in urologic care, is reinventing patient education and clinic efficiency ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.